Lysophosphatidic acid enhances vascular endothelial growth factor-C expression in human prostate cancer PC-3 cells

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Lin, Chuan En ^a   Chen, Shee Uan ^a   Lin, Chu Cheng ^a   Chang, Chi Hao ^a   Lin, Yueh Chien ^a   Tai, Yu Ling ^a   Shen, Tang Long ^a   Lee, Hsinyu ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOTAXIN; BIOLOGICAL MARKER; LENS EPITHELIUM DERIVED GROWTH FACTOR; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHATIDIC ACID RECEPTOR 1; LYSOPHOSPHATIDIC ACID RECEPTOR 3; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; VASCULOTROPIN C;

ARTICLE; AUTOTAXIN GENE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME MECHANISM; ENZYME REGULATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE SILENCING; HUMAN; HUMAN CELL; MALE; PHOSPHOLIPID SYNTHESIS; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; REGULATOR GENE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; VASCULOTROPIN C GENE;

CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYSOPHOSPHOLIPIDS; MALE; PHOSPHORIC DIESTER HYDROLASES; PROSTATIC NEOPLASMS; REACTIVE OXYGEN SPECIES; RECEPTORS, LYSOPHOSPHATIDIC ACID; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

DANIO RERIO;

EID: 84864082480     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041096     Document Type: Article

References (44)

1. Arya M, Bott SR, Shergill IS, Ahmed FU, Williamson M, et al. (2006) The metastatic cascade in prostate cancer. Surgical Oncology-Oxford 15: 117-128.
2. Su JL, Yen CJ, Chen PS, Chuang SE, Hong CC, et al. (2007) The role of the VEGF-C/VEGFR-3 axis in cancer progression. British Journal of Cancer 96: 541-545.
3. Zeng YP, Opeskin K, Horvath LG, Sutherland RL, Williams ED, (2005) Lymphatic vessel density and lymph node metastasis in prostate cancer. Prostate 65: 222-230.
4. Zeng YP, Opeskin K, Baldwin ME, Horvath LG, Achen MG, et al. (2004) Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer. Clinical Cancer Research 10: 5137-5144.
5. Brakenhielm E, Burton JB, Johnson M, Chavarria N, Morizono K, et al. (2007) Modulating metastasis by a lymphangiogenic switch in prostate cancer. International Journal of Cancer 121: 2153-2161.
6. Burton JB, Priceman SJ, Sung JL, Brakenhielm E, An DS, et al. (2008) Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis. Cancer Research 68: 7828-7837.
7. Choi JW, Herr DR, Noguchi K, Yung YC, Lee CW, et al. (2010) LPA receptors: subtypes and biological actions. Annu Rev Pharmacol Toxicol 50: 157-186.
8. Noguchi K, Herr D, Mutoh T, Chun J, (2009) Lysophosphatidic acid (LPA) and its receptors. Curr Opin Pharmacol 9: 15-23.
9. Liu S, Murph M, Panupinthu N, Mills GB, (2009) ATX-LPA receptor axis in inflammation and cancer. Cell Cycle 8: 3695-3701.
10. Liu SY, Umezu-Goto M, Murph M, Lu YL, Liu WB, et al. (2009) Expression of Autotaxin and Lysophosphatidic Acid Receptors Increases Mammary Tumorigenesis, Invasion, and Metastases. Cancer Cell 15: 539-550.
11. Zeng Y, Kakehi Y, Nouh MA, Tsunemori H, Sugimoto M, et al. (2009) Gene expression profiles of lysophosphatidic acid-related molecules in the prostate: relevance to prostate cancer and benign hyperplasia. Prostate 69: 283-292.
12. Hama K, Aoki J, Fukaya M, Kishi Y, Sakai T, et al. (2004) Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1. J Biol Chem 279: 17634-17639.
13. Hwang YS, Hodge JC, Sivapurapu N, Lindholm PF, (2006) Lysophosphatidic acid stimulates PC-3 prostate cancer cell matrigel invasion through activation of RhoA and NF-kappa B activity. Molecular Carcinogenesis 45: 518-529.
14. Xie Y, Meier KE, (2004) Lysophospholipase D and its role in LPA production. Cell Signal 16: 975-981.
15. van Meeteren LA, Moolenaar WH, (2007) Regulation and biological activities of the autotaxin-LPA axis. Prog Lipid Res 46: 145-160.
16. Jonkers J, Moolenaar WH, (2009) Mammary tumorigenesis through LPA receptor signaling. Cancer Cell 15: 457-459.
17. Nouh M, Wu XX, Okazoe H, Tsunemori H, Haba R, et al. (2009) Expression of Autotaxin and Acylglycerol kinase in prostate cancer: Association with cancer development and progression. Cancer Science 100: 1631-1638.
18. Enholm B, Paavonen K, Ristimaki A, Kumar V, Gunji Y, et al. (1997) Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene 14: 2475-2483.
19. Lee SJ, Chan TH, Chen TC, Liao BK, Hwang PP, et al. (2008) LPA1 is essential for lymphatic vessel development in zebrafish. FASEB J 22: 3706-3715.
20. Lin CI, Chen CN, Huang MT, Lee SJ, Lin CH, et al. (2008) Lysophosphatidic acid upregulates vascular endothelial growth factor-C and tube formation in human endothelial cells through LPA(1/3), COX-2, and NF-kappaB activation- and EGFR transactivation-dependent mechanisms. Cell Signal 20: 1804-1814.
21. Lin CI, Chen CN, Huang MT, Lee SJ, Lin CH, et al. (2008) Lysophosphatidic acid up-regulates vascular endothelial growth factor-C and lymphatic marker expressions in human endothelial cells. Cellular and Molecular Life Sciences 65: 2740-2751.
22. Cohen B, Addadi Y, Sapoznik S, Meir G, Kalchenko V, et al. (2009) Transcriptional Regulation of Vascular Endothelial Growth Factor C by Oxidative and Thermal Stress Is Mediated by Lens Epithelium-Derived Growth Factor/p75. Neoplasia 11: 921-U271.
23. Rinaldo F, Li J, Wang E, Muders M, Datta K, (2007) RalA regulates vascular endothelial growth factor-C (VEGF-C) synthesis in prostate cancer cells during androgen ablation. Oncogene 26: 1731-1738.
24. Sharma P, Singh DP, Fatma N, Chylack LT Jr, Shinohara T, (2000) Activation of LEDGF gene by thermal-and oxidative-stresses. Biochem Biophys Res Commun 276: 1320-1324.
25. Shinohara T, Singh DP, Fatma N, (2002) LEDGF, a survival factor, activates stress-related genes. Prog Retin Eye Res 21: 341-358.
26. Mediavilla-Varela M, Pacheco FJ, Almaguel F, Perez J, Sahakian E, et al. (2009) Docetaxel-induced prostate cancer cell death involves concomitant activation of caspase and lysosomal pathways and is attenuated by LEDGF/p75. Mol Cancer 8: 68.
27. Sapoznik S, Cohen B, Tzuman Y, Meir G, Ben-Dor S, et al. (2009) Gonadotropin-regulated lymphangiogenesis in ovarian cancer is mediated by LEDGF-induced expression of VEGF-C. Cancer Res 69: 9306-9314.
28. Xie YH, Gibbs TC, Mukhin YV, Meier KE, (2002) Role for 18: 1 lysophosphatidic acid as an autocrine mediator in prostate cancer cells. Journal of Biological Chemistry 277: 32516-32526.
29. Panupinthu N, Lee HY, Mills GB, (2010) Lysophosphatidic acid production and action: critical new players in breast cancer initiation and progression. Br J Cancer 102: 941-946.
30. Kishi Y, Okudaira S, Tanaka M, Hama K, Shida D, et al. (2006) Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid. J Biol Chem 281: 17492-17500.
31. Ferry G, Moulharat N, Pradere JP, Desos P, Try A, et al. (2008) S32826, a nanomolar inhibitor of autotaxin: discovery, synthesis and applications as a pharmacological tool. J Pharmacol Exp Ther 327: 809-819.
32. Hao F, Tan M, Xu X, Han J, Miller DD, et al. (2007) Lysophosphatidic acid induces prostate cancer PC3 cell migration via activation of LPA(1), p42 and p38alpha. Biochim Biophys Acta 1771: 883-892.
33. Ward Y, Lake R, Yin JJ, Heger CD, Raffeld M, et al. (2011) LPA receptor heterodimerizes with CD97 to amplify LPA-initiated RHO-dependent signaling and invasion in prostate cancer cells. Cancer Res 71: 7301-7311.
34. Park JJ, Rubio MV, Zhang Z, Um T, Xie Y, et al. (2012) Effects of lysophosphatidic acid on calpain-mediated proteolysis of focal adhesion kinase in human prostate cancer cells. Prostate April 2 [Epub ahead of print].
35. Park SY, Jeong KJ, Lee J, Yoon DS, Choi WS, et al. (2007) Hypoxia enhances LPA-induced HIF-1alpha and VEGF expression: their inhibition by resveratrol. Cancer Letters 258: 63-69.
36. Li J, Wang E, Rinaldo F, Datta K, (2005) Upregulation of VEGF-C by androgen depletion: the involvement of IGF-IR-FOXO pathway. Oncogene 24: 5510-5520.
37. Aziziyeh AI, Li TT, Pape C, Pampillo M, Chidiac P, et al. (2009) Dual regulation of lysophosphatidic acid (LPA(1)) receptor signalling by Ral and GRK. Cellular Signalling 21: 1207-1217.
38. Lin CI, Chen CN, Huang MT, Lee SJ, Lin CH, et al. (2008) Lysophosphatidic acid upregulates vascular endothelial growth factor-C and tube formation in human endothelial cells through LPA(1/3), COX-2, and NF-kappa B activation- and EGFR transactivation-dependent mechanisms. Cellular Signalling 20: 1804-1814.
39. Daniels T, Zhang J, Gutierrez I, Elliot ML, Yamada B, et al. (2005) Antinuclear autoantibodies in prostate cancer: immunity to LEDGF/p75, a survival protein highly expressed in prostate tumors and cleaved during apoptosis. Prostate 62: 14-26.
40. Zeng Y, Kakehi Y, Nouh M, Tsunemori H, Sugimoto M, et al. (2009) Gene expression Profiles of Lysophosphatidic Acid-Related Molecules in the Prostate: Relevance to Prostate Cancer and Benign Hyperplasia. Prostate 69: 283-292.
41. Rhim JH, Kim SA, Lee JE, Kim DJ, Chung HK, et al. (2008) Cancer cell-derived IL-1alpha induces IL-8 release in endothelial cells. J Cancer Res Clin Oncol 134: 45-50.
42. Reinmuth N, Rensinghoff S, Raedel M, Fehrmann N, Schwoppe C, et al. (2007) Paracrine interactions of vascular endothelial growth factor and platelet-derived growth factor in endothelial and lung cancer cells. Int J Oncol 31: 621-626.
43. Zeng Y, Opeskin K, Goad J, Williams ED, (2006) Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis. Cancer Res 66: 9566-9575.
44. Lin JM, Lalani AS, Harding TC, Gonzalez M, Wu WW, et al. (2005) Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor. Cancer Research 65: 6901-6909.